GTN0 Stock Overview
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 15.30 |
| 52 Week High | SEK 19.90 |
| 52 Week Low | SEK 15.00 |
| Beta | 0.49 |
| 11 Month Change | -14.53% |
| 3 Month Change | -13.07% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -3.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| GTN0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -7.3% | -3.7% | -0.5% |
| 1Y | n/a | -4.2% | 8.3% |
Return vs Industry: Insufficient data to determine how GTN0 performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how GTN0 performed against the German Market.
Price Volatility
| GTN0 volatility | |
|---|---|
| GTN0 Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GTN0 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: GTN0's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,848 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
| GTN0 fundamental statistics | |
|---|---|
| Market cap | €4.06b |
| Earnings (TTM) | €146.17m |
| Revenue (TTM) | €2.90b |
27.8x
P/E Ratio1.4x
P/S RatioIs GTN0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GTN0 income statement (TTM) | |
|---|---|
| Revenue | SEK 33.59b |
| Cost of Revenue | SEK 18.21b |
| Gross Profit | SEK 15.39b |
| Other Expenses | SEK 13.69b |
| Earnings | SEK 1.69b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 28, 2025
| Earnings per share (EPS) | 6.21 |
| Gross Margin | 45.80% |
| Net Profit Margin | 5.03% |
| Debt/Equity Ratio | 30.0% |
How did GTN0 perform over the long term?
See historical performance and comparison